Statistics

Total Visits

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial66

Select a period of time:

Number of views in the range

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial4

Views

Views
November 20250
December 20252
January 20260
February 20260
March 20260
April 20260
May 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
Germany1
Panama1
Singapore1
United States1
 

Top cities views

Views
Frankfurt am Main1
Panama City1